APA (7th ed.) Citation

LM, B., D, D. G., V, J., M, V., SE, G., M, A., . . . A, B. (2025). LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment. BMC cancer, 25(1), 496. https://doi.org/10.1186/s12885-025-13889-4

Chicago Style (17th ed.) Citation

LM, Berclaz, et al. "LDH and Hemoglobin Outperform Systemic Inflammatory Indices as Prognostic Factors in Patients with Soft Tissue Sarcoma Undergoing Neoadjuvant Treatment." BMC Cancer 25, no. 1 (2025): 496. https://doi.org/10.1186/s12885-025-13889-4.

MLA (9th ed.) Citation

LM, Berclaz, et al. "LDH and Hemoglobin Outperform Systemic Inflammatory Indices as Prognostic Factors in Patients with Soft Tissue Sarcoma Undergoing Neoadjuvant Treatment." BMC Cancer, vol. 25, no. 1, 2025, p. 496, https://doi.org/10.1186/s12885-025-13889-4.